{"title":"Vitamin D association with systemic sclerosis and its clinical features: A systematic review, meta-analysis, and meta-regression.","authors":"Tarak Dhaouadi, Awatef Riahi, Taïeb Ben Abdallah, Yousr Gorgi, Imen Sfar","doi":"10.1177/23971983241288591","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>The aim of this review was to summarize existing data on the contribution of Vitamin D level and/or deficiency/insufficiency to systemic sclerosis susceptibility and its clinical features.</p><p><strong>Methods: </strong>An electronic literature search for eligible studies among all papers published prior to 30 June 2024 was conducted through PubMed, EMBASE, Web of science, and Scopus databases. Meta-analyses estimating pooled raw mean differences, odds ratios, and Pearson <i>r</i> together with subgroup analyses and meta-regressions were performed for the association of Vitamin D with susceptibility to systemic sclerosis and disease presentation.</p><p><strong>Results: </strong>Combined analysis revealed a significant decrease in Vitamin D level in systemic sclerosis patients comparatively to healthy controls, with raw mean differences 95% CI = -11.68 [-15.43 to -7.92] ng/mL, <i>p</i> < 1 E-10. Likewise, Vitamin D insufficiency (Vitamin D < 30 ng/mL) and deficiency (<10 ng/mL) were significantly associated with systemic sclerosis; odds ratios 95% CI = 3.58 [2.59-4.95], <i>p</i> < 1 E-10 and odds ratios 95% CI = 7.67 [3.97-14.83], <i>p</i> < 1 E-10, respectively. Moreover, decreased Vitamin D level was significantly associated with interstitial lung disease occurrence (raw mean differences 95% CI = -3.61 [-6.93 to -0.3], <i>p</i> = 0.003), while Vitamin D deficiency was associated with increased systolic pulmonary arterial pressure, raw mean differences (95% CI = 4.17 [1.44-6.89], <i>p</i> = 0.003). Besides, Vitamin D level was negatively correlated with the modified Rodnan skin score, <i>r</i> (95% CI = -0.26 [-0.44 to -0.08], <i>p</i> = 0.004). Conversely, Vitamin D level was significantly increased in systemic sclerosis patients with cutaneous calcinosis, raw mean differences (95% CI = 4.18 [1.07-7.28], <i>p</i> = 0.008).</p><p><strong>Conclusion: </strong>This meta-analysis showed that decreased Vitamin D level was associated with susceptibility to systemic sclerosis, interstitial lung disease occurrence, increased systolic pulmonary arterial pressure, and higher modified Rodnan skin score. Conversely, calcinosis was found to be associated with increased Vitamin D level.</p><p><strong>Registration: </strong>This review has been registered on PROSPERO: CRD42024565045, available from: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42024565045.</p>","PeriodicalId":17036,"journal":{"name":"Journal of Scleroderma and Related Disorders","volume":" ","pages":"23971983241288591"},"PeriodicalIF":1.4000,"publicationDate":"2024-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11559530/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Scleroderma and Related Disorders","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/23971983241288591","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives: The aim of this review was to summarize existing data on the contribution of Vitamin D level and/or deficiency/insufficiency to systemic sclerosis susceptibility and its clinical features.
Methods: An electronic literature search for eligible studies among all papers published prior to 30 June 2024 was conducted through PubMed, EMBASE, Web of science, and Scopus databases. Meta-analyses estimating pooled raw mean differences, odds ratios, and Pearson r together with subgroup analyses and meta-regressions were performed for the association of Vitamin D with susceptibility to systemic sclerosis and disease presentation.
Results: Combined analysis revealed a significant decrease in Vitamin D level in systemic sclerosis patients comparatively to healthy controls, with raw mean differences 95% CI = -11.68 [-15.43 to -7.92] ng/mL, p < 1 E-10. Likewise, Vitamin D insufficiency (Vitamin D < 30 ng/mL) and deficiency (<10 ng/mL) were significantly associated with systemic sclerosis; odds ratios 95% CI = 3.58 [2.59-4.95], p < 1 E-10 and odds ratios 95% CI = 7.67 [3.97-14.83], p < 1 E-10, respectively. Moreover, decreased Vitamin D level was significantly associated with interstitial lung disease occurrence (raw mean differences 95% CI = -3.61 [-6.93 to -0.3], p = 0.003), while Vitamin D deficiency was associated with increased systolic pulmonary arterial pressure, raw mean differences (95% CI = 4.17 [1.44-6.89], p = 0.003). Besides, Vitamin D level was negatively correlated with the modified Rodnan skin score, r (95% CI = -0.26 [-0.44 to -0.08], p = 0.004). Conversely, Vitamin D level was significantly increased in systemic sclerosis patients with cutaneous calcinosis, raw mean differences (95% CI = 4.18 [1.07-7.28], p = 0.008).
Conclusion: This meta-analysis showed that decreased Vitamin D level was associated with susceptibility to systemic sclerosis, interstitial lung disease occurrence, increased systolic pulmonary arterial pressure, and higher modified Rodnan skin score. Conversely, calcinosis was found to be associated with increased Vitamin D level.
Registration: This review has been registered on PROSPERO: CRD42024565045, available from: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42024565045.
目的:本综述旨在总结维生素 D 水平和/或缺乏/不足与系统性硬化症易感性及其临床特征相关的现有数据:本综述旨在总结维生素 D 水平和/或缺乏/不足对系统性硬化症易感性及其临床特征的现有数据:通过PubMed、EMBASE、Web of science和Scopus数据库对2024年6月30日之前发表的所有论文中符合条件的研究进行电子文献检索。对维生素 D 与系统性硬化症易感性和疾病表现的关系进行了汇总原始均值差异、几率比、Pearson r、亚组分析和元回归等元分析:综合分析显示,与健康对照组相比,系统性硬化症患者的维生素 D 水平明显下降(原始均值差异 95% CI = -11.68 [-15.43 to -7.92] ng/mL,p p p = 0.003),而维生素 D 缺乏与收缩期肺动脉压升高有关(原始均值差异 95% CI = 4.17 [1.44-6.89],p = 0.003)。此外,维生素 D 水平与改良罗德南皮肤评分呈负相关,r (95% CI = -0.26 [-0.44 to -0.08],p = 0.004)。相反,伴有皮肤钙化的系统性硬化症患者的维生素 D 水平明显升高,原始平均差(95% CI = 4.18 [1.07-7.28],P = 0.008):这项荟萃分析表明,维生素 D 水平的降低与系统性硬化症的易感性、间质性肺病的发生、肺动脉收缩压的升高以及改良罗德南皮肤评分的升高有关。相反,钙化症则与维生素 D 水平升高有关:本综述已在 PROSPERO 上注册:CRD42024565045,可从以下网址获取:https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42024565045。